Theorems and implications of a model independent elimination/distribution function decomposition of linear and some nonlinear drug dispositions. I. Derivations and theoretical analysis
- 1 December 1984
- journal article
- research article
- Published by Springer Nature in Journal of Pharmacokinetics and Biopharmaceutics
- Vol. 12 (6) , 627-648
- https://doi.org/10.1007/bf01059557
Abstract
The approach presented enables a model independent representation of the pharmacokinetics of drugs with a linear disposition and some drugs with a nonlinear disposition. The approach is based on a decomposition of the drug disposition into an elimination function q(c) and a distribution function h(t). The qfunction represents the net effect of all disposition processes which work toward a reduction in the systemic drug level. The hfunction represents the net effect of all disposition processes which slow down the rate of decline of the systemic drug level by returning drug from the peripheral environment to the systemic circulation. Several theorems relating qand hto the drug disposition are presented which uniquely define these functions mathematically. The disposition decomposition is of particular significance in three main areas of pharmacokinetics: (1) evaluation of drug absorption, (2) drug level predictions including steady state predictions, and (3)elucidation of drug disposition kinetics. The practical significance of the decomposition method in these three areas is discussed, and various procedures for the application of the method are proposed. The decomposition method represents a model independent alternative to pharmacokinetic models such as linear compartmental models, the recirculation model, and some physiologic models. This also includes nonlinear forms of such models, as long as the nonlinearity is due to a central nonlinear elimination. The greatest promise and significance of the disposition decomposition approach appears to be its application to nonlinear pharmacokinetics. In contrast to linear pharmacokinetics the kinetic analysis in such cases has been limited to model dependent methods employing specific pharmacokinetic models, due to the lack of model independent alternatives. The novel development presented offers such alternatives. For some applications these alternatives appear more rational in the sense that the analysis becomes more general and objective and may be based on fewer assumptions.Keywords
This publication has 14 references indexed in Scilit:
- A linear recirculation model for drug dispositionJournal of Pharmacokinetics and Biopharmaceutics, 1979
- Linear systems analysis in pharmacokineticsJournal of Pharmacokinetics and Biopharmaceutics, 1978
- General Treatment of Linear PharmacokineticsJournal of Pharmaceutical Sciences, 1978
- Nonlinear assessment of phenytoin bioavailabilityJournal of Pharmacokinetics and Biopharmaceutics, 1976
- Phenytoin: Pharmacokinetics and bioavailabilityClinical Pharmacology & Therapeutics, 1976
- Bioavailability and single‐dose pharmacokinetics of intramuscular phenytoinClinical Pharmacology & Therapeutics, 1975
- Bioavailability calculations for drugs showing simultaneous first-order and capacity-limited elimination kineticsJournal of Pharmacokinetics and Biopharmaceutics, 1973
- Transfer times across the human bodyBulletin of Mathematical Biology, 1972
- Preliminary Model for Methotrexate PharmacokineticsJournal of Pharmaceutical Sciences, 1970
- Theory of transport in linear biological systems: I. Fundamental integral equationBulletin of Mathematical Biology, 1960